Investigation of solid-state reactions using variable temperature X-ray powder diffractometry. II. Aminophylline monohydrate

Pharmaceutical Research

Volumn 19, Issue 9, 2002, Pages 1265-1273

  Rastogi, S K ^a,b   Zakrzewski, M ^c,d   Suryanarayanan, R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b FOREST RESEARCH INSTITUTE   (United States)

^c MALVERN INSTRUMENTS LTD   (United Kingdom)

^d Advanced Solid State Analysis International Inc   (United States)

Author keywords

Aminophylline; Decomposition; Kinetics; Solid state; Theophylline; X ray powder diffractometry

Indexed keywords

AMINOPHYLLINE; THEOPHYLLINE;

ARTICLE; CHEMICAL REACTION KINETICS; DRUG DECOMPOSITION; DRUG FORMULATION; HIGH TEMPERATURE; LOW TEMPERATURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOLID STATE; TEMPERATURE DEPENDENCE; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

AMINOPHYLLINE; POWDER DIFFRACTION; TEMPERATURE; THEOPHYLLINE; X-RAY DIFFRACTION;

EID: 0036744867     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020386321876     Document Type: Article

References (28)

1. J. Haleblian and W. McCrone. Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58:911-929 (1969).
2. D. C. Monkhouse and L. van Campen. Solid state reactions-theoretical and experimental aspects. Drug Dev. Ind. Pharm. 10:1175-1276 (1984).
3. H. G. Brittain. Overview of Physical Characterization Methodology. In H. G. Brittain (ed.), Physical Characterization of Pharmaceutical Solids, Marcel Dekker, Inc., New York, 1995, pp. 1-35.
4. S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and G. Poochikian. Pharmaceutical solids: a strategic approach to regulatory considerations. Pharm. Res. 12:945-954 (1995).
5. N. V. Phadnis and R. Suryanarayanan. Polymorphism in anhydrous theophylline-implications on the dissolution rate of theophylline tablets. J. Pharm. Sci. 86:1256-1263 (1997).
6. H. G. Brittain. Polymorphism in Pharmaceutical Solids, Marcel Dekker, New York, 1999.
7. S. R. Byrn, R. R. Pfeiffer, and J. G. Stowell. Solid State Chemistry of Drugs, 2nd edition, SSCI, West Lafayette, Indiana, 1999.
8. K. A. Connors, G. L. Amidon, and V. J. Stella. Chemical Stability of Pharmaceuticals: a Handbook for Pharmacists, Wiley, New York, 1986.
9. J. Han and R. Suryanarayanan. Influence of environmental conditions on the kinetics and mechanism of dehydration of carbamazepine dihydrate. Pharm. Dev. Tech. 3:587-596 (1998).
10. R. Suryanarayanan. X-ray powder diffractometry. In H. G. Brittain (ed.), Physical Characterization of Pharmaceutical Solids, Marcel Dekker, New York, 1995, pp. 187-223.
11. S. K. Rastogi and R. Suryanarayanan. Characterization of Delivery Systems, X-ray Powder Diffraction. In E. Mathiowitz (ed.), Encyclopedia of Controlled Release, John Wiley and Sons, New York, 1999, pp. 275-285.
12. S. P. Duddu, A. Khin-Khin, D. J. W. Grant, and R. Suryanarayanan. A novel X-ray powder diffractometric method for studying the reaction between pseudoephedrine enantiomers. J. Pharm. Sci. 86:340-345 (1997).
13. E. Shefter, H. L. Fung, and O. Mok. Dehydration of crystalline theophylline monohydrate and ampicillin trihydrate. J. Pharm. Sci. 62:791-794 (1973).
14. Y. Li, J. Han, G. G. Z. Zhang, D. J. W. Grant, and R. Suryanarayanan. In situ dehydration of carbamazepine dihydrate-a novel technique to prepare amorphous anhydrous carbamazepine. Pharm. Dev. Tech. 5:257-266 (2000).
15. J. Han and R. Suryanarayanan. A method for the rapid evaluation of the physical stability of pharmaceutical hydrates. Thermochim. Acta 329:163-170 (1999).
16. H. Hashizume, S. Shimomura, H. Yamada, T. Fujita, and H. Nakazawa. An X-ray diffraction system with controlled relative humidity and temperature. Powder Diffr. 11:288-289 (1996).
17. R. A. Kuhnel and S. J. van der Gaast. Humidity controlled diffractometry and its applications. Adv. X-ray Anal. 36:436-449 (1993).
18. S. K. Rastogi, M. Zakrzewski, and R. Suryanarayanan. Investigation of solid-state reactions in pharmaceutical systems using variable temperature X-ray powder diffractometry. I. Aspartame hemihydrate. Pharm. Res. 18:267-273 (2001).
19. K. D. Thakker and L. T. Grady. Aminophylline. In K. Florey (ed.), Analytical Profiles of Drug Substances, Academic Press, New York, 1982, pp. 1-44.
20. Y. Kawashima, S. Aoki, H. Takenaka, and Y. Miyake. Preparation of spherically agglomerated crystals of aminophylline. J. Pharm. Sci. 73:1407-1410 (1984).
21. J. Nishijo and F. Takenaka. Studies of the properties of the complex medicines. I. Differential thermogravimetric analysis of Aminophylline. J. Pharm. Soc. Jap. 99:824-829 (1979).
22. Y. Ishiguro, M. Sawada, K. Ohmayu, and K. Kawabe. On the volatility of ethylenediamine from aminophylline. J. Pharm. Soc. Jap. 102:211-214 (1982).
23. P. L. Klug and L. E. Alexander. X-ray Diffraction Procedures for Polycrystalline and Amorphous Materials, Wiley, New York, 1974.
24. Powder Diffraction File (PDF-2), International Centre for Diffraction Data, Newtown Square, Pennsylvania, 1996.
25. J. T. Carstensen. Stability of solids and solid dosage forms. J. Pharm. Sci. 63:1-14 (1974).
26. E. Y. Shalaev, M. Shalaeva, S. R. Byrn, and G. Zografi. Effects of processing on the solid-state methyl transfer of tetraglycine methyl ester. Int. J. Pharm. 152:75-88 (1997).
27. H. Schmalzreid. Chemical Kinetics of solids, VCH Verlagsgesellschaft mbH, Weinheim, Germany, 1995.
28. The United States Pharmacopeia/The National Formulary, 24th revision, United States Pharmacopeial Convention, Rockville, MD, 1999, p. 115.